Dynamx Bioadaptor: Superior Results in Complex Coronary Cases
Elixir Medical, a company dedicated to developing innovative treatments for cardiovascular diseases, has released promising data from its INFINITY-SWEDEHEART...
Nalmefene and Naloxone for Fentanyl-Induced Respiratory Depression
A recent study published in The Journal of Clinical Pharmacology reveals that intramuscular nalmefene effectively reverses fentanyl-induced respiratory depression....
Early TAVR Superiority in Asymptomatic Severe Aortic Stenosis
The EARLY TAVR Trial, a groundbreaking study, evaluated the optimal approach to treating asymptomatic severe aortic stenosis (AS). It...
Organon Completes Acquisition of Dermavant
Organon, a global healthcare company focused on women’s health, has finalized its acquisition of Dermavant Sciences Ltd. from Roivant....
Boomi, Base Life Science Partner to Boost Digital Transformation
Boomi, a leader in intelligent integration and automation, has partnered with BASE Life Science, an Infosys company specializing in...
Aditxt Finalizes Evofem Merger Investment
Aditxt, Inc., a company focused on driving health innovations, has reached a significant milestone in acquiring Evofem Biosciences, Inc.,...
How to Alleviate Clinical Trial Burden at Study Sites
In this interview, Joseph Kim, Chief Strategy Officer at ProofPilot, shares how to revolutionize clinical trials at study sites....
New EDPB Opinion: Vendors in Clinical Trials
The European Data Protection Board (EDPB) recently issued Opinion 24/2024, focusing on a critical aspect of data protection compliance:...
Unpacking FDA Guidance on Digital Health Technologies in Clinical Trials
Digital Health Technologies (DHTs) use in clinical research is no longer a futuristic concept—it’s quickly becoming the norm. Recognizing...
Leo Pharma Presents Long-Term Adbry® Trial Results at Fall Clinical 2024
LEO Pharma Inc., a leader in medical dermatology, announced the final results of ECZTEND, a five-year study on Adbry®...